Peritoneal albumin and protein losses do not predict outcome in peritoneal dialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 3, 2011, Pages 561-566

  Balafa, Olga ^a   Halbesma, Nynke ^b   Struijk, Dirk G ^a,c   Dekker, Friedo W ^b   Krediet, Raymond T ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c Dianet Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 2 MACROGLOBULIN; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CREATININE; IMMUNOGLOBULIN G; PROTEIN; SERUM ALBUMIN;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ARTICLE; COMORBIDITY; DIALYSATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERITONEAL DIALYSIS; PERMEABILITY; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ALPHA-MACROGLOBULINS; BETA 2-MICROGLOBULIN; BLOOD PROTEINS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; FEMALE; HUMANS; HYPOALBUMINEMIA; IMMUNOGLOBULIN G; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NETHERLANDS; PERITONEAL DIALYSIS; PERITONEUM; PERMEABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79953005060     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05540610     Document Type: Article

References (34)

1. Krediet RT, Zuyderhoudt FM, Boeschoten EW, Arisz L: Peritoneal permeability to proteins in diabetic and non-diabetic continuous ambulatory peritoneal dialysis patients. Nephron 42: 133-140, 1986
2. Imholz AL, Koomen GC, Voorn WJ, Struijk DG, Arisz L, Krediet RT: Day-to-day variability of fluid and solute transport in upright and recumbent positions during CAPD. Nephrol Dial Transplant 13: 146-153, 1998
3. Zemel D, Krediet RT, Koomen GC, Struijk DG, Arisz L: Day-to-day variability of protein transport used as a method for analyzing peritoneal permeability in CAPD. Perit Dial Int 11: 217-223, 1991
4. Krediet RT, Zemel D, Imholz AL, Koomen GC, Struijk DG, Arisz L: Indices of peritoneal permeability and surface area. Perit Dial Int 13: S31-S34, 1993
5. Kaysen GA: Biological basis of hypoalbuminaemia in ESRD. J Am Soc Nephrol 9: 2368-2376, 1998
6. De Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet R, Dekker FW: Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 19: 127-135, 2009
7. Friedman AN, Fadem SZ: Reassessment of albumin as a nutritional marker in kidney disease. J Am Soc Nephrol 21: 223-230, 2010
8. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Arisz L: The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 14: 121-126, 1994
9. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. The Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 9: 1285-1292, 1998
10. Margetts PJ, McMullin J, Rabbat CG, Churchill DN: Peritoneal membrane transport and hypoalbuminemia: Cause or effect? Perit Dial Int 20: 14-18, 2000
11. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B: Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 19: 17-22, 1999
12. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: Peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17: 2591-2598, 2006
13. Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17: 271-278, 2006
14. Wiggins KJ, McDonald SP, Brown FG, Rosman JB, Johnson DW: High membrane transport status on peritoneal dialysis is not associated with reduced survival following transfer to haemodialysis. Nephrol Dial Transplant 22: 3005-3012, 2007
15. Yang X, Fang W, Bargman JM, Oreopoulos DG: High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis. Perit Dial Int 28: 82-92, 2008
16. Chung SH, Heimburger O, Lindholm B: Poor outcomes for fast transporters on PD: The rise and fall of a clinical concern. Semin Dial 21: 7-10, 2008
17. Heaf JG, Sarac S, Afzal S: A high peritoneal large pore fluid flux causes hypoalbuminaemia and is a risk factor for death in peritoneal dialysis patients. Nephrol Dial Transplant 20: 2194-2201, 2005
18. Perl J, Huckvale K, Chellar M, John B, Davies SJ: Peritoneal protein clearance and not peritoneal membrane transport status predicts survival in a contemporary cohort of peritoneal dialysis patients. Clin J Am Soc Nephrol 4: 1201-1206, 2009
19. Sanchez-Villanueva A, Bajo MA, Del PG, Fernandes AP, Gonzalez E, Romero S, Estrada S, Selgas R: Higher daily peritoneal protein clearance when initiating peritoneal dialysis is independently associated with peripheral arterial disease (PAD): A possible new marker of systemic endothelial dysfunction? Nephrol Dial Transplant 24: 1009-1014, 2009
20. Van Biesen W, Van der Tol A, Veys N, Dequidt C, Vijt D, Lameire N, Vanholder R: The personal dialysis capacity test is superior to the peritoneal equilibration test to discriminate inflammation as the cause of fast transport status in peritoneal dialysis patients. Clin J Am Soc Nephrol 1: 269-274, 2006
21. Nakamoto H, Imai H, Kawanishi H, Nakamoto M, Minakuchi J, Kumon S, Watanabe S, Shiohira Y, Ishii T, Kawahara T, Tsuzaki K, Suzuki H: Effect of diabetes on peritoneal function assessed by personal dialysis capacity test in patients undergoing CAPD. Am J Kidney Dis 40: 1045-1054, 2002
22. Szeto CC, Chow KM, Lam CW, Cheung R, Kwan BC, Chung KY, Leung CB, Li PK: Peritoneal albumin excretion is a strong predictor of cardiovascular events in peritoneal dialysis patients: A prospective cohort study. Perit Dial Int 25: 445-452, 2005
23. Pannekeet M, Imholz A, Struijk DG, Koomen GC, Langedijk M, Schouten N, de Waart R, Hiralall J, Krediet RT: The standard peritoneal permeability analysis: A tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int 48: 866-875, 1995
24. Smit W, van Dijk P, Langedijk MJ, Schouten N, van den Berg N, Struijk DG, Krediet RT: Peritoneal function and assessment of reference values using a 3.86% glucose solution. Perit Dial Int 23: 440-449, 2003
25. Krediet RT, Struijk DG, Koomen GC, Arisz L: Peritoneal fluid kinetics during CAPD measured with intraperitoneal dextran 70. ASAIO Trans 37: 662-667, 1991
26. Davies SJ: Assessment of comorbidity in peritoneal dialysis patients. Contrib Nephrol 140: 98-103, 1993
27. Liew YP, Bartholomew JR, Demirjian S, Michaels J, Schreiber MJ Jr.: Combined effect of chronic kidney disease and peripheral arterial disease on all-cause mortality in a high-risk population. Clin J Am Soc Nephrol 3: 1084-1089, 2008
28. Krediet R: Physiology of High/Fast transporters. In: Textbook of Peritoneal Dialysis, 3rd Ed., edited by Khanna R, Krediet R, New York, Springer, 2009, pp 173-181
29. van Esch S, Zweers MM, Jansen MA, de Waart DR, van Manen JG, Krediet RT: Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients. Perit Dial Int 24: 554-561, 2004
30. Oh KH, Jung JY, Yoon MO, Song A, Lee H, Ro HHY, Kim DK, Margetts P, Ahn C: Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 25: 1639-1646, 2010
31. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J: Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 14: 1871-1879, 2003
32. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albumin in patients on continuous ambulatory peritoneal dialysis-predictors and correlations with outcome. J Am Soc Nephrol 3: 1501-1517, 1993
33. Dulaney JT, Hatch FE: Peritoneal dialysis and loss of proteins. Kidney Int 26: 253-262, 1984
34. Doumas BT, Peters T Jr.: Serum and urine albumin: A progress report on their measurement and clinical significance. Clin Chim Acta 258: 3-20, 1997